Literature DB >> 1852475

Age-specific acquisition of immunity to infective larvae in a bancroftian filariasis endemic area of Papua New Guinea.

K P Day1, W F Gregory, R M Maizels.   

Abstract

The development of antibodies to infective stages of the filarial parasite, Wuchereria bancrofti, with age of the host human population was studied by immunofluorescence, immunoprecipitation and immunoblotting assays. Among individuals under 20 years of age, few had detectable antibodies to the infective (L3) larval surface by IFA: only 2 out of 10 scored positive. However, all adults (over 20 years) were positive in this assay although the utilization of isotypes varied between different individuals. Whilst antibodies to the L3 surface are therefore acquired after prolonged exposure to infection (greater than 20 years), recognition patterns of L3 surface labelled antigens, measured by immunoprecipitation analysis iodinated proteins on SDS-PAGE, and of somatic L3 proteins on immunoblots, were equivalent in the two age groups. Thus, a critical surface antigen, recognised in an age-dependent manner, is present on the L6 cuticle but cannot be resolved as a conventional protein or glycoprotein constituent.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1852475     DOI: 10.1111/j.1365-3024.1991.tb00282.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  16 in total

1.  Human bancroftian filariasis - a role for antibodies to parasite carbohydrates.

Authors:  M C Mohanty; A K Satapathy; P K Sahoo; B Ravindran
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis.

Authors:  W F Gregory; A K Atmadja; J E Allen; R M Maizels
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

3.  The immunodominant Brugia malayi paramyosin as a marker of current infection with Wuchereria bancrofti adult worms.

Authors:  S Langy; C Plichart; P Luquiaud; S A Williams; L Nicolas
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Immunoglobulin G subclass responses of children during infection with Onchocerca volvulus.

Authors:  A A Gbakima; T B Nutman; J E Bradley; L A McReynolds; M D Winget; Y Hong; A L Scott
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

5.  Past exposure and the dynamics of lymphatic filariasis infection in young children.

Authors:  A Srividya; P K Das; S Subramanian; K D Ramaiah; B T Grenfell; E Michael; D A Bundy
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

6.  Diminished monocyte function in microfilaremic patients with lymphatic filariasis and its relationship to altered lymphoproliferative responses.

Authors:  B Sasisekhar; M Aparna; D J Augustin; P Kaliraj; S K Kar; T B Nutman; R B Narayanan
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

7.  The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age.

Authors:  Fidelis Cho-Ngwa; Jing Liu; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2010-08-24

8.  Cloning and characterization of a potentially protective chitinase-like recombinant antigen from Wuchereria bancrofti.

Authors:  N Raghavan; D O Freedman; P C Fitzgerald; T R Unnasch; E A Ottesen; T B Nutman
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  A novel 95-kilodalton antigen of Wuchereria bancrofti infective larvae identified by species-specific monoclonal antibodies.

Authors:  T R Burkot; G E Kwan-Lim; R M Maizels
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

10.  Host protective immunity and vaccine development studies in lymphatic filariasis.

Authors:  M V Reddy; R Alli; B C Harinath
Journal:  Indian J Clin Biochem       Date:  2000-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.